IN BRIEF: Arm's Haas to leave AstraZeneca board amid new SoftBank role
AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Rene Haas will step down as a non-executive director on Thursday next week, the end of April, due to his increased executive duties. Haas is the chief executive officer of UK-based computer-chip designer Arm Holdings PLC and earlier this week was named to the additional role of CEO of SoftBank Group International. Japanese technology investor SoftBank Group Corp remains a major shareholder in Arm following its New York listing in 2023, retaining a 90% stake at the time. Read More